Founder’s Journey

Scientific Breakthroughs and Global Contributions
Dr. Wani began his scientific career working on tumor suppressor genes at the Center for Biotechnology, Jawaharlal Nehru University, New Delhi, and was part of India’s first genome project at the Center for DNA Fingerprinting and Diagnostics, Hyderabad. His drive for discovery gave him an opportunity to be invited as a Guest Scientist at the German National Center for Environment & Health, Munich, Germany, where he studied the role of gene and stem cell therapies in retinitis pigmentosa. Dr. Wani earned his Ph.D. degree in Human Molecular Biology from the Ludwig Maximilian University of Munich, becoming the first scientist to link nitric oxide to gene expression in kidney diseases. His quest for research has laid the foundation for multiple innovations in diagnostics, drug development and nanotechnology.

Entrepreneurial Milestones
In 2008, Dr. Wani founded BioCentra LLC, which has since spun off three successful biotech ventures. His notable achievements include the development of an affordable hepatitis C viral load test, bringing critical healthcare solutions to developing countries. He raised $250,000 and partnered with the Centers for Disease Control (CDC) to conduct clinical trials involving over 100 patients, demonstrating his ability to secure funding and manage large-scale projects.

Industry Leadership and Disruptive Innovation
Dr. Wani continued to push boundaries with the development of one of the first nano-formulations of cannabinoids in 2018, pioneering new approaches in product development. In 2020, he founded TopBlood LLC, the first Covid-19 diagnostics lab in Austin, which was sold in 2022. This success further solidified his reputation as a leader in diagnostics. He followed this by establishing BioCentra Diagnostics in 2021, a CAP and CLIA accredited high complexity infectious disease diagnostics laboratory, which is now recognized for its cutting-edge contributions to patient care.

Vision for the Future
In 2024, Dr. Wani introduced TBioScan™, a revolutionary diagnostic tool for traumatic brain injury (TBI). TBioScan™ has the potential to transform TBI diagnosis and treatment globally, offering significant market opportunities. Beyond his scientific achievements, Dr. Wani is deeply committed to mentorship and education, serving as an advisor to initiatives like Muslims Achieving Excellence (MAX). His unique ability to merge science, entrepreneurship, and community impact positions him as a leader capable of driving future innovations in healthcare.

Dr. Javid A. Wani, Ph.D.